Micah Meisel is a Managing Director of InTandem Capital. Before joining InTandem in January 2018, he was a Managing Director at middle market private equity fund J.H. Whitney Capital Partners, LLC where he focused on healthcare investing. At J.H. Whitney, Mr. Meisel was responsible for sourcing, structuring and executing transactions as well as driving portfolio company value creation.
He has led investments in and served as a Director, or Board Observer, on numerous healthcare and wellness related companies, including TIDI Products, Precision for Medicine, Caris Life Sciences, United BioSource Corporation and Human Touch.
Mr. Meisel has an MBA from The Tuck School of Business at Dartmouth, where he was an Edward Tuck Scholar, and a BA from Tufts University.